Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
Clinical trial NCT03675685 · COMPLETED
Trial details
- NCT number
- NCT03675685
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2018-11-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.